Trials / Completed
CompletedNCT00909389
Post-marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients (Study P05647)
Post - Marketing Surveillance of the Safety, Tolerability and Efficacy of Vytorin (Ezetimibe + Simvastatin) Tablet Among Filipino Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,748 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to establish the safety, tolerability, and efficacy of Vytorin (R) (Ezetimibe + Simvastatin) (SCH 465981) on a select population of Filipinos with hypercholesterolemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vytorin (R) (Ezetimibe + Simvastatin) | Vytorin (R) (Ezetimibe + Simvastatin) 1 tablet once daily to be taken by mouth in the evening for 28 days |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2008-11-01
- Completion
- 2008-11-01
- First posted
- 2009-05-28
- Last updated
- 2022-02-09
- Results posted
- 2011-10-04
Source: ClinicalTrials.gov record NCT00909389. Inclusion in this directory is not an endorsement.